Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study

BACKGROUND: The iron-based phosphate binder (PB), sucroferric oxyhydroxide (SFOH), is indicated to control serum phosphorus levels in patients with chronic kidney disease on dialysis. METHODS: This non-interventional, prospective, multicentre, cohort study conducted in seven European countries evalu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Kidney J
Hlavní autoři: Vervloet, Marc G, Boletis, Ioannis N, de Francisco, Angel L M, Kalra, Philip A, Ketteler, Markus, Messa, Piergiorgio, Stauss-Grabo, Manuela, Derlet, Anja, Walpen, Sebastian, Perrin, Amandine, Ficociello, Linda H, Rottembourg, Jacques, Wanner, Christoph, Cannata-Andía, Jorge B, Fouque, Denis
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2021
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8243278/
https://ncbi.nlm.nih.gov/pubmed/34221384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfaa211
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky